Glycoalkaloid combinations and various uses thereof
US12357649B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Inventors
Key dates
| Filing date | Mar 3, 2017 |
| Grant date | Jul 15, 2025 |
| Priority date | — |
| Expiry date | May 22, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of glycoalkaloids, such as solasonine and solamargine, in treatment of cancer such as skin cancer, and to compositions for use in such treatment. More particularly the present invention relates to providing an improved, substantially stable formulation for the glycoalkaloids which minimises or reduces degradation of these active molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.